4//SEC Filing
Tesi Raymond Joseph 4
Accession 0001213900-22-014507
CIK 0001711754other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 4:33 PM ET
Size
7.3 KB
Accession
0001213900-22-014507
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
- Award
Common Stock
2022-03-22$8.43/sh+23,724$199,993→ 1,514,398 total - Award
Option (right to buy)
2022-03-21+130,000→ 130,000 totalExercise: $7.92Exp: 2032-03-20→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities . These shares were purchased by the Reporting Person directly from Issuer.
- [F2]Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767280
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 4:33 PM ET
- Size
- 7.3 KB